SCBIO believes growing the life sciences sector will significantly transform the state’s economy. see more
Compliments of the Community Journal...
It was all smiles on Sept. 30 as BMW marked the 25th anniversary of the first vehicle to roll off its Spartanburg assembly line, a singular moment that dramatically transformed the economic face of South Carolina.
A quarter-century after opening, the German manufacturer’s North American facility employs more than 11,000 workers who build 1,500 vehicles daily, a pace requiring the services of more than 40 main suppliers across the state.
The average wage among all S.C. jobs supported by the automotive industry stood at $64,120 in 2017 compared to $40,293 across all employment categories, say findings commissioned by the South Carolina Biotechnology Industry Organization (SCBIO).
Now three years old, SCBIO is spearheading an aggressive initiative to make South Carolina the preferred location for new or expanding companies in another highly promising industry: life sciences. Read the entire story by clicking here.
DPX publishes new application note see more
DPX recently published a new application note “Automated Method for High-Throughput LC-MS/MS Quantitation of Testosterone from Serum: An Improved Validated Method” where a new ultra pure grade filtration tip was introduced. The method for the extraction of testosterone from serum used Low Porosity Filtration Tips- Ultra Pure (LPFT-UP) and incorporated a ZnSO4 solution in addition to acetonitrile on a Hamilton Heater Shaker (HHS) for improved recovery and precision during protein precipitation. The LPFT-UP provide a high purity filtration media for methods with very low detection limits.
Patient samples had a calculated recovery of testosterone at 99.5% with no detected matrix effects. This demonstrates that the use of ZnSO4 and acetonitrile is very efficient in extracting testosterone, and the use of ultra pure grade tips (LPFT-UP) resulted in negligible losses. The introduction of Low Porosity Filtration tips- Ultra Pure provides a new product for low detection level methods.
“We are really excited to expand our product offering for steroid testing,” said Carmen Adamson, brand manager. DPX plans to expand on the research and development to include a full panel of steroids. “Testosterone imbalance can signal a problem in both men and women. This method provides an accurate and precise tool to aid in that determination,” said Evan DiVirgilio, application scientist. DPX continues to provide methods for efficient sample processing for clinical and forensic laboratories.
DPX Technologies manufactures patented sample preparation products and specializes in custom workflows for a diverse client base including clinical, forensic, food safety, and pharmaceutical industries. Their products offer INTip™ sample preparation solutions that are compatible with semi-automated and fully automated liquid handling systems. This enables high sample throughput and high laboratory efficiency.
# # #
About DPX Technologies
DPX is committed to providing innovative sample purification solutions. We collaborate with our customers to provide the high-quality products they need for complex chemical and biological analysis.
Okra Medical donates face masks to 8 hospitals see more
Okra Medical, a life sciences start-up company based on Johns Island, South Carolina, donated nearly 100,000 healthcare face masks to eight hospitals and one pediatric group serving on the frontlines of the COVID-19 pandemic. The majority of the masks are smaller in size to benefit children and young adults.
“Like many in America, the coronavirus brought our business to a standstill,” said Marshall Hartmann, CEO, Okra Medical. “We redirected our laboratory efforts to securing medical supplies to both help fund our payroll and to give back to our community.”
Okra Medical had planned to launch the company’s new pharmaceutical drug destroyer, SafeMedWaste in mid-March. Then COVID-19 hit. The leadership team started looking for ways to leverage their international relationships to support the company and the community. They landed on securing PPE for the healthcare industry.
“We are overwhelmed with gratitude for the waves of donations received from the Charleston community. Most donors have said that they don’t need or want any thanks, they just want to help in any way they can, and assisting them by providing an avenue to receive has been an honor. As we try to stay focused and rise to the strategic challenges we’re all being faced with, the impact these donations are having, on both a personal and national level, is incredible.” Jennifer Simon, MUSC.
MUSC is one of eight hospitals benefiting from Okra Medical’s donations. The full list is:
- Medical University of South Carolina, Charleston, SC
- Roper St. Francis Healthcare, Charleston, SC
- Coastal Pediatric Associates, North Charleston, SC
- Prisma Health, Greenville, SC
- Shriners Hospital for Children, Greenville, SC
- Conway Medical Center, Conway, SC
- WakeMed Children’s Hospital, Raleigh, NC
- Cincinnati Children's Hospital Medical Center, Cincinnati, OH
- University of Pittsburgh Medical Center Children’s Hospital, Pittsburg, PA
“We are thankful for the health care heroes willing to serve at a time like this,” said Hartmann. “Giving back is the easy part. U.S. Senator Tim Scott’s Office and SCBIO made donating even easier by providing helpful guidance to match donors with organizations in need.”
“The rapid response of Senator Tim Scott’s team allowed us to quickly get donation masks into the hands of people who needed them most,” said Justin Stas, Chief Technical Officer, Okra Medical. “We are very proud of the way our South Carolina community, from government to individuals, has come together during this difficult time.”
SCBIO is South Carolina’s investor-driven public/private economic development organization exclusively focused on building, advancing, and growing the life sciences industry in the state. The industry has more than 675 firms, including Okra Medical, directly involved and 43,000 professionals employed directly or indirectly in the research, development and commercialization of innovative healthcare, medical device, industrial, environmental and agricultural biotech and products. The state-wide nonprofit represents companies in the advanced medicines, medical devices, equipment, diagnostics, IT, and healthcare outcome industries.
“We continue to be humbled by the amazing and impactful response to this public health crisis by SCBIO stakeholders like Okra Medical. Their gracious donation of thousands of critically important pediatric healthcare face masks to help ensure the safety of children in hospital environments during this global pandemic is a great example of Okra’s culture of servant leadership combined with their business expertise and innovativeness. We’re very proud and grateful that they are a highly engaged member of our organization,” said Sam Konduros, President/CEO of SCBIO.
A member of SCBIO, Okra Medical has developed and validated a patented product called SafeMedWaste that will simplify the way pharmaceutical manufacturers, hospitals, and individuals destroy and dispose of highly-addictive controlled substances like opioids. To learn more about the environmentally-friendly product, watch this video on the company website.
About Okra Medical Inc.
Okra Medical, Inc., headquartered in Johns Island, South Carolina, specializes in product development, manufacturing and strategic sourcing of controlled pharmaceutical substance disposal solutions. Founded in 2018, the Company’s mission is to improve public health. Its best-in-class suite of SafeMedWaste products use single formulas that are fully compliant with DEA regulations requiring non-retrievable destruction of controlled substances. Okra Medical is a strategic sourcing partner to hospitals, hospice facilities, law enforcement agencies, pharmaceutical manufacturers, and veterinary care clinics. Visit www.okramedical.com.
South Carolina Launches COVID-19 Emergency Supply Portal to Connect Providers with Organizations in NeedSouth Carolina launches portal to connect critical supplies with those who need them see more
SCMEP, South Carolina Hospital Association, SC Department of Commerce and SCBIO combine
to source critical medical supplies and get them to parties in need quickly
South Carolina – April 13, 2020 – A collaboration between SCMEP, the SC Hospital Association, the SC Department of Commerce and SCBIO has resulted in the expedited launch of a new online South Carolina Emergency Supply Collaborative web portal.
Located at www.SCCOVID19.org, the portal connects parties in need of essential supplies and equipment with those that can provide it in quickly and efficiently. It allows industry and community partners with the ability to quickly produce, source, test, certify or contribute critical medical supplies (such as face shields, gowns, ventilators and masks) to directly connect with the healthcare providers, first responders and members of industry in search of those essential supply needs in one easy step.
Manufacturers able to expand or pivot their production lines, suppliers and distributors with access to ready-made supplies, organizations able to donate supplies or personal protective equipment (PPE) can identify the supplies and equipment they can offer in the site’s central repository. Once quickly reviewed and vetted by a team from the collaborative, organizations in need of the materials will be digitally connected through the portal to secure their desired goods from providers directly.
The need for the portal was identified after members of the collaborative began individually fielding hundreds of calls from organizations in need of such supplies, said Chuck Spangler, President of the South Carolina Manufacturing Extension Partnership (SCMEP).
“Each of our respective organizations has strong and indelible positions as sources of information, connection and aid to our respective constituencies, so it was logical for those parties – whether hospitals or manufacturers, existing industry or life sciences organizations – to turn to us in time of need,” said Mr. Spangler. “After sharing among ourselves the flood of requests we were individually receiving and trying to manage, we determined that a combined approach would offer greatest value and efficiency for our state and its citizens, and the creation of the South Carolina COVID-19 Emergency Supply portal was quickly underway.”
The site identifies critical need items as evidenced by industry, healthcare, first responder and governmental audiences across the state, and allows organizations to quickly enter the type of goods they can provide or manufacture, quantities and production capacity, and supply chain needs or requirements. Once entered and vetted by the SCMEP team, inquiring parties seeking the goods will be connected to the providers through the portal. Organizations then conduct transactions and arrange and plan logistics directly.
“This is a joint effort to recruit community partners with ability to quickly source or provide needed medical supplies to support South Carolina’s COVID-19 response,” said Thornton Kirby, President and CEO of the SC Hospital Association. “South Carolina’s COVID-19 Emergency Supply website will save valuable time and effort in connecting those in need of goods with those who have them… at a time where every minute counts in saving lives and defeating this formidable virus.”
The COVID-19 Emergency Supply website will be updated constantly with new information and opportunities to support South Carolina emergency response efforts. It also links directly to individual websites of the four Collaborative partners, which each provide a host of resources, news, connections and relevant information for businesses and individuals.
“We are all in this together, and I am proud of the South Carolina business community’s continued response to serve our state during this unprecedented time,” said S.C. Secretary of Commerce Bobby Hitt. “The COVID-19 Emergency Supply Collaborative’s ability to connect manufacturers, suppliers and other organizations with the front-line medical personnel who need these critical items will serve as a valuable resource.”
Organizations and individuals can go online 24/7 to identify critical need items or to note what products they can provide or may need, said Sam Konduros, CEO of SCBIO. “We encourage every member of industry, if you have a product that is needed and which you can provide, produce, test, certify or donate, let us know that right now by completing the simple form on the site. And for organizations in need of such items, let us know that right away so that we can get connect you with parties who can help right now.”
Visit the new site at https://sccovid19.org/
A message from SCBIO's CEO see more
Unprecedented steps are being taken by all of us – businesses and families alike – as we collectively combat the Coronavirus global pandemic that is hitting far too close to home. What was once a news story unfolding in Wuhan, China, only a few months ago has now become a harsh reality right here in the Palmetto State.
As of today, South Carolina has well over 1,000 confirmed cases of COVID-19, and the death rate is starting to climb – and COVID-19 “hotspots” like New York and New Orleans clearly demonstrate how rapidly this situation can deteriorate if we fail to do our parts with regard to social distancing, hand washing, and adhering to the mandate to stay at home as much as possible. The economic hardships accompanying the healthcare impacts of this horrific virus are painfully real and will hit many companies and citizens without mercy. None of us will be untouched, and the toughest days are still ahead…
On a truly encouraging note, collaboration, cooperation, innovation, and goodwill are being displayed by our stakeholders. SCBIO is integrating our efforts and resources closely with numerous fellow associations, agencies and organizations on a simultaneous basis. The SC Department of Commerce, SC Hospital Association, SC Manufacturing Extension Partnership, and the SC Research Authority are only a few of our respected partners that we are working virtually with on a daily basis to do whatever is possible to address vital needs. This potentially catastrophic event is spurring amazing ideas and heroic efforts that will echo for decades to come.
The life sciences and healthcare industries are valiantly front and center as the beacons of hope for conquering this invisible foe. SCBIO is grateful to have a relevant role on the COVID-19 battlefield but is most humbled to see the brilliance and resourcefulness of the companies and organizations we support and represent. There are far too many examples to highlight, but we are so proud of large and small member companies like Nephron Pharmaceuticals, Vikor Scientific, Precision Genetics, Thorne, Abbott Labs, and Humimic that have fearlessly stepped-up, retooled, and refocused to rapidly create desperately needed solutions to arm clinicians and healthcare providers with vital tools they need to effectively carry out their mission to literally save lives – ranging from COVID-19 test kits to respiratory therapies to face shields.
In our role as the Palmetto State’s life sciences industry lead organization, SCBIO has aggressively pivoted our activities to adapt to the demands of the current crisis, making significant decisions to keep our focus where it needs to be – and to demonstrate prioritization of our own work program in a manner that directly relates with the realities that our state and nation are facing. We want and need to hear from you about your efforts – and anything we can do to help.
As meaningful as it is to gather and convene, until some point in the future, nobody needs to be talking about conferences or sponsorships – and the thought of gathering hundreds of people is almost unimaginable at present. Based on that unavoidable truth – and our commitment to be an impactful problem-solver in this crisis – our signature SCBIO Annual Conference has been shifted from its historical time frame of October (2020) to February 16-18, 2021 in Charleston. For SCBIO, it’s a significant and symbolic decision that we felt compelled to make now to demonstrate our conviction to remain focused on COVID-19 issues for as long as is necessary. Likewise, our quarterly board meeting has been rescheduled from April 8th to June 18th at Furman University, with the hope that we might be able to safely convene as we approach early Summer. Until then, all our meetings will be virtual through the blessings of technology.
In closing, SCBIO’s current focus will continue to be:
- Solving supply chain issues by linking life sciences solution providing companies with healthcare providers and clinicians as rapidly as possible
- Working collaboratively with complementary agencies and organizations to solve issues that are challenging our industry, as well as healthcare professionals on the front lines treating patients in need
- Seeking capital and offering support to companies that have novel solutions to combat COVID-19 – but need assistance to scale up
- Conducting weekly webinars on highly relevant topics and COVID-19-related issues to various targeted audiences, ranging from FDA navigation and compliance to small business assistance to leading-edge science-based updates regarding the Coronavirus
- Retrieving and disseminating substantive and data-based/critical information about COVID-19 and making it readily available on our website’s dedicated Coronavirus portal (www.scbio.org)
- Markedly increasing our overall communications by providing two newsletters per month, and launching a short update every week with our new Monday Moment series – featuring crucial updates and member companies that are making a difference, with a little inspiration on the side
- Maintaining a steady series of virtual meetings with companies and organizations across the state and beyond to continue building and advancing life sciences in South Carolina
- Pursuing new grants and funding for high-impact workforce, innovation, and economic development strategies that can directly contribute to our mission
- Honing our infrastructure and skill sets with the goal of becoming the most effective statewide life sciences industry organization in America
- And, finally… Helping whoever we can, whenever we can – as unforeseen opportunities continue to present themselves daily
It is easy for an atmosphere of fear and anxiousness to hang in the air at a time like this, and each of us will experience some of that on certain days in such an alien season of life. But we can’t give into that. We are strong individually, but infinitely stronger together…we need God and each other more than ever, and there truly is a unique opportunity during this to learn, grow, and become better.
Our planet depends on Life Sciences… What a privilege for all of us to be part of that. Let’s fight the battle courageously, together – and seize the opportunity that has been presented.
Wishing all of you health, safety, and peace – Godspeed,
#ONWARD #gamefaceon #TeamSC #SCHelps
David Zaas, M.D., named CEO for MUSC Health - Charleston Div. and Chief Clinical Officer for MUSC HealthDavid Zaas Named to executive post at MUSC see more
Patrick J. Cawley, M.D., CEO for MUSC Health and vice president for Health Affairs, University, named David Zaas, M.D., MBA, as the new chief executive officer, MUSC Health - Charleston Division, and chief clinical officer for MUSC Health. In these roles, Zaas will report directly to Cawley, who leads the entire MUSC Health statewide system. Following a national search, Zaas was recommended for this major leadership position by a search committee co-chaired by Prabhakar Baliga, M.D., chair, Department of Surgery, and Lisa Montgomery, MHA, MUSC executive vice president, Finance and Operations. Zaas is scheduled to join MUSC in July.
As the CEO of MUSC Health - Charleston, Zaas will lead the MUSC Hospital Authority in Charleston, including the MUSC Shawn Jenkins Children’s Hospital and Pearl Tourville Women’s Pavilion. He will oversee the executive leadership team of the MUSC Health - Charleston Division and serve on the MUSC Health System Council, as CEO of our flagship hospital. His responsibility as chief clinical officer will involve providing guidance and advice on health care system strategies.
“Dr. Zaas has a deep appreciation for academic medicine and its critical role in research and innovation,” Cawley said. “He has a history of leading and promoting successful collaboration among a university, practice plan and health system. In addition, he is a profound advocate for patient and family centeredness and has a demonstrated track record of leading clinical growth, financial success and top performance in quality and safety. We look forward to the many contributions he can make to our health system,” he added.
Prior to accepting his new role, Zaas served as president of Duke Raleigh Hospital since 2014. His previous leadership positions at Duke University in Durham, North Carolina, include: chief medical officer, Duke Faculty Practice Diagnostic Clinic; medical director, Duke University Hospital; vice chair, Department of Medicine, Duke University; and medical director for Lung and Heart-Lung Transplantation, Duke University Hospital. He has played a central role in advancing multiple key strategic initiatives for Duke Health, including care redesign, clinical integration and improving access for patients.
Zaas holds a B.A. in biology from Yale University, an M.D. from Northwestern University Medical School, and an MBA from Duke University. He completed his internal medicine residency at Johns Hopkins Hospital and fellowship in pulmonary and critical care at Duke University. Zaas’s academic interests have involved both translational and clinical research focused on improving outcomes from lung transplantation including the role of infectious complications after transplant.
About MUSC Health
As the clinical health system of the Medical University of South Carolina (MUSC), MUSC Health is dedicated to delivering the highest quality patient care available, while training generations of competent, compassionate health care providers to serve the people of South Carolina and beyond. Comprising some 1,600 beds, more than 100 outreach sites, the MUSC College of Medicine, the physicians’ practice plan, and nearly 275 telehealth locations, MUSC Health owns and operates eight hospitals situated in Charleston, Chester, Florence, Lancaster and Marion counties. In 2019, for the fifth consecutive year, U.S. News & World Report named MUSC Health the No. 1 hospital in South Carolina. To learn more about clinical patient services, visit muschealth.org.
Founded in 1824, MUSC and its affiliates have collective annual budgets of $3.2 billion. The more than 17,000 MUSC team members include world-class faculty, physicians, specialty providers and scientists who deliver groundbreaking education, research, technology and patient care. For information on academic programs, visit musc.edu.
Nephron, Ritedose to the rescue with respiratory drugs see more
Two South Carolina companies that make drugs used to treat respiratory illnesses and symptoms, like those experienced by people infected with the coronavirus, have upped their production amid increased demand.
Nephron Pharmaceuticals in West Columbia and Ritedose Corp. make generic versions of almost all the respiratory drugs used in the United States, including albuterol sulfate and ipratropium bromide, according to the CEOs of the two companies.
Business at Nephron spiked last week, CEO Lou Kennedy said, with orders up 48 percent. The CEO of Ritedose, Jody Chastain, said his company has received a slight increase in demand. Click to read full story, courtesy of The Post and Courier...
Subject matter leaders from across Palmetto State to cover what businesses need to know see more
March 9, 2020 – SCBIO will host a full day program March 17 -- Life Sciences Boot Camp: Insights on SC’s Fastest-Growing Industry – to inform and update businesses and professionals from across the state on opportunities, trends and issues facing South Carolina’s fastest-growing industry segment.
To be held at the SC Hospital Association’s Yates Conference Center in Columbia, the program will run from 8:30 a.m. until 1 p.m. and will feature a light breakfast followed by presentations from over 15 noted life sciences industry leaders. Confirmed topics and speakers include:
- Best Practices in Life Sciences Recruiting & Retention – addressing how the state’s life sciences leaders are attracting, training and retaining top talent will be Lou Kennedy, CEO of Nephron Pharmaceuticals; Shawn Regan, CEO of Rhythmlink; Andrew Lee, Founder of IMCS, and Matt Vaadi, CEO of ERG
- Partnering Effectively with Higher Education & Research Universities – ways to tap into the wealth of resources, knowledge and experience prevalent in the state’s higher education and research universities will be explained by a panel comprised of Anthony Herrera, Executive Director of Furman University Entrepreneurship & Innovation; Angela Lockman, Director of Partnerships and Strategic Initiatives for Clemson University; Chad Hardaway, Assoc. Director of the University of South Carolina Office of Economic Engagement; Carol Moore, President of Columbia College; and Michael Rusnak, Executive Director, MUSC Foundation for Research Development
- Accessing Capital to Grow Your Life Sciences Organization – the secrets to finding capital to grow and expand your organization, from start-up to growth company, will be unveiled by John Osborne, Principal with Good Growth Capital; Jill Sorensen, Executive Director of SC Launch; and Tyler Tatum of 3Phase SC
- Attracting & Retaining Life Sciences Organizations – three economic development experts will share how the Palmetto State is going about growing the life sciences industry here, and what plans are to make it even more attractive tomorrow. Speaking will be Stephanie Few, Partner with Womble Bond Dickinson; Jeremy Migliara, Shareholder with Elliott Davis; and Will Clarke, Manager with Elliott Davis
- Protecting Your Life Sciences Organization from Cybercrime – will be addressed by cybersecurity expert Delano Collins, Vice President of Cybersecurity with Corsica Technologies. He’ll address how planning defense in depth -- from network and systems security to industry compliance and employee training -- can set organizations up for security and success.
SCBIO Investor Organizations receive one registration at no charge, and additional attendees from Investor organizations as well as SCBIO registered Members pay only $50 for the program. The general public and Non-Members can attend for just $100. Fees include the full program, plus a light breakfast and lunch. To register or for more details, visit the Events page at www.SCBIO.org/. Interested students and media members are invited to attend, with advance registration, at no cost.
SCBIO is South Carolina’s investor-driven public/private economic development organization exclusively focused on building, advancing, and growing the life sciences industry in the state. The industry has an $11.4 billion annual economic impact in the Palmetto State, with more than 675 firms directly involved and 43,000 professionals employed in the research, development and commercialization of innovative healthcare, medical device, industrial, environmental and agricultural biotech and products. The state-wide nonprofit has offices in Greenville, Columbia, and Charleston, and represents companies in the advanced medicines, medical devices, equipment, diagnostics, IT, and healthcare outcome industries. Life sciences is recognized as the fastest-growing segment of South Carolina’s knowledge economy.
MUSC Shawn Jenkins Children’s Hospital and Pearl Tourville Women’s Pavilion open see more
The long-awaited MUSC Shawn Jenkins Children’s Hospital and Pearl Tourville Women’s Pavilion opened Saturday, bringing a dedicated space for women’s and children’s health care to the Lowcountry.
In just under 12 hours, Medical University of South Carolina staff and partners transported almost 200 patients from the former MUSC Children’s Hospital on Ashley Avenue to the new building on the corner of Courtenay Drive and Calhoun Street.
“We saw an incredible amount of teamwork and a very professional approach to the whole thing, but also just a whole lot of joy,” said Mark Scheurer, MUSC Children’s Hospital chief medical officer and project leader. “It was really fun just watching the little things happen that you talked about in the planning period when they were just hypothetical.”
The 11-story hospital includes the state’s only level-one pediatric trauma and burn unit and the state’s largest level-four NICU.
Starting with patients in the neonatal intensive care unit, teams simultaneously transported patients along four routes with the use of 36 ambulances, Scheurer said.
The 11-story, 625,000-square-foot hospital includes a 20% increase in capacity. It has the state’s only level-one pediatric trauma and burn unit and the state’s largest level-four NICU. There also is an advanced fetal care center and a dedicated elevator for transporting mothers in labor from the hospital’s entrance directly to the fourth-floor maternity pavilion.
“This new hospital is so important for the community because it will offer a different experience for women and children and their families because they (the team) will be able to deliver care using new technology,” said Carolyn Donohue, MUSC’s executive director of nursing for children’s and women’s health. “It also involves our patients to be able to use that technology to improve their ability to communicate with the health care team and their family during the acute care of their hospitalization.”
This $389 million project was expected to open in October and then December. Neither opening took place delayed after setbacks from Hurricane Dorian and because the hospital didn’t pass safety and regulatory inspections.
The hospital began its operating room and outpatient services Monday. Staff members will continue to move in any remaining supplies and equipment and to monitor operations to make sure they work as smoothly as planned.
MUSC receives top honor from SC Hospital Association see more
Tidelands Health and MUSC Health are the inaugural winners of the South Carolina Hospital Association’s (SCHA) Capstone Award, a recognition of hospitals and health systems in South Carolina who are leaders in pursuing excellence in delivering highly reliable care, developing a healthy workforce, and building healthy communities. Awarded in conjunction with Live Healthy SC, the state’s first-ever health improvement plan, the Capstone Award serves as the highest honor that SCHA bestows each year and represents the expansive efforts and extraordinary results that South Carolina hospitals are achieving for their patients and communities every day.
Since 2015, Tidelands Health has led an organization-wide high reliability initiative that has enhanced their culture of safety by engaging their board on the issue and creating a robust reporting system for quality and patient safety incidents. Tidelands Health is a leader in expanding access and care through their Tidelands Community Care Network, a regional initiative designed to help uninsured and underinsured individuals access timely care. Tidelands Health has made community health a top priority, providing community education about healthier living and hosting events that provide health screenings to the public at little or no cost.
Similarly, MUSC has implemented a suite of best practices to improve care delivery with constant communication and rounding practices, including weekly safety rounds, daily safety huddles, and daily check in calls. The system has a special Office of Health Promotion (OHP) to create a culture of wellbeing with initiatives and activities to support that culture, including the acclaimed MUSC Urban Farm. MUSC also has expansive community health efforts that include Healthy Tri-County, a multi-sector regional initiative in partnership with Trident Health and United Way to improve health outcomes in Berkeley, Charleston, and Dorchester counties. They’ve also implemented programs to address food insecurity with Kids Eat Free at MUSC, and the Farmacy, a weekly offering of free fresh produce and health information in downtown Charleston.
SCHA is tremendously proud of our two Capstone Award winners for exemplifying the values that drive our hospitals to establish a better state of health.
South Carolina Hospital Association is a private, not-for-profit organization made up of some 100 member hospitals and health systems and about 900 personal members associated with our institutional members. The South Carolina Hospital Association was created in 1921 to serve as the collective voice of the state’s hospital community. Together, we are building a better state of health.
SCRA Making Huge Contributions to SC business and job growth see more
New Report Spotlights Heavy-Hitting Contributions to State Business and Job Growth
In Fiscal Year 2019 (FY19), the South Carolina Research Authority (SCRA) played a major role in boosting jobs and technology-related businesses in South Carolina, with 2.9% technology sector job growth—close to double that of general statewide employment gains—and an impact of $694.38 million on the overall innovation economy. An annual report released this week quantifies metrics and shares the success stories behind these positive statewide trends resulting from the efforts of SCRA and its clients and partners in research, academia, entrepreneurship and industry. Click here to read the full story, compliments of Midlands Biz.
DPX unveils new brand, website see more
Columbia, SC – DPX Technologies, a manufacturer of laboratory consumable products, announces the launch of a new brand image. DPX has been manufacturing pipette tips for sample preparation since 2007. Their patented technologies are available across the U.S., and DPX plans to increase sales internationally.
The rebrand includes a new company logo, website and other marketing collateral. DPX also updated the product lines with a trademark for the name INTip™. Product lines include INTip™ Solid Phase Extraction and INTip™ Filtration. This strategic brand update aligns product segments within different industries and highlights pipette tip technology for sample preparation.
The future of DPX lies in the proteomics and genomics industries. Dr. Brewer sees a big future with INTip products for protein purification and DNA purification. “INTip compliments the existing core technology and delivers the new brand expansion for pipette tip products in market segments where automated sample preparation is highly sought after,” said Dr. Brewer, founder and CEO of DPX Technologies. “Pipette tips are easy to use and easy to automate, which will increase efficiency, robustness and reproducibility for protein purification and DNA purification.”
DPX products are currently sold across the U.S., Canada and in Brazil. “We are starting to pick up leads in Europe, Australia and China. We are excited about expanding our product offerings internationally,” said Bill Kemnitzer, PhD., Director of Sales and Business Development.
# # #
About DPX Technologies
DPX is committed to providing innovative sample purification solutions. We collaborate with our customers to provide the high-quality products they need for complex chemical and biological analysis. Visit them at https://dpxtechnologies.com/.
Alcami's $17 million investment is expected to create 30 new jobs see more
Alcami Corporation, a leading provider of fully-integrated custom end-to-end solutions for the pharmaceutical and biologics industries, today announced plans to expand the company’s current operations in Charleston County. The $17 million investment is expected to create 30 new jobs.
Operating in North Charleston since 2001, Alcami offers a variety of solutions tailored to small and midsized pharmaceutical and biotechnology companies.
Located at 4221 Faber Place Drive in North Charleston, S.C., Alcami will add approximately 6,000 square feet to the footprint of its facility, substantially augmenting the capacity of its sterile drug product development and manufacturing operations.
The company’s expansion is expected to be completed in 2021. Individuals interested in joining the Alcami team should visit https://www.alcaminow.com/alcami-careers.
The Coordinating Council for Economic Development has approved job development credits related to the project.
“The build-out of our Charleston facility comes at a time of rapid growth for Alcami and represents a long-term commitment to our sterile drug product clients, our talented workforce and the greater Charleston area. Our clients expect the most advanced manufacturing technologies and capabilities, and this expansion will ensure we continue to exceed marketplace expectations by remaining on the forefront of industry needs.” -Alcami Site Director Darold Hill
“When a company like Alcami Corporation continues to invest in our state and our people, it shows the businesses around the world that South Carolina is the place to be. We look forward to seeing this great company continue to grow and thrive for years to come.” –Gov. Henry McMaster
“We’re excited to see the continued success of Alcami Corporation in Charleston County and the success of our state’s thriving manufacturing industry. We congratulate them on this newest announcement and the creation of 30 new jobs.” –Secretary of Commerce Bobby Hitt
“The growth of Alcami Corporation during its 18 years in North Charleston has been truly remarkable. This company is a highly-valued corporate citizen, and with this expansion, it is renewing its steadfast and long-standing commitment to our community.” –Charleston County Council Chairman Elliott Summey
“We applaud Alcami’s accomplishments in our local economy, building upon their company’s innovation, which is backed by a proven workforce. North Charleston remains ripe for businesses to flourish, and we are always grateful for the benefits our community receives when companies succeed.” –North Charleston Mayor Keith Summey
“Congratulations to Alcami on announcing their second expansion in Charleston County in the last three years. Assisting local companies in their expansion efforts is a primary focus of our Business Concierge program. Our long-standing relationship with Alcami helped support their decision to grow their global footprint at their North Charleston facility.” –Charleston County Economic Development Executive Director Steve Dykes
Universities are the largest job creators in two thirds of America's largest cities see more
Human psychology primes us to see marquee projects like Amazon's HQ2 as the pinnacle of economic development. Big-name corporate partners capture people’s imagination, with promises of new jobs and state-of-the-art campuses that will revitalize long-stagnant neighborhoods, practically overnight. However, perspective can be easily lost in all this excitement. For every region like the Washington D.C. metro area that secures an HQ2-like award, there are hundreds of other places that thrive off lower-profile, but no less important, economic anchors.
Universities, for example, are the largest job creators in 66 of the 100 largest U.S. cities. Part of the reason that these figures do not regularly make headlines is that they have been regarded as gospel for generations of economic developers.
Read how, through the thought leadership of University of South Carolina’s (UofSC) former president, Dr. Harris Pastides, USC proactively confronted this challenge. Click for full article from Route Fifty.
Greenwood Genetic Center, MUSC affiliate to improve patient access to innovations in genetic servicesMUSC partners with Greenwood Genetic Center see more
The Greenwood Genetic Center (GGC) and the Medical University of South Carolina (MUSC) have signed an affiliation agreement with the goal of providing patients across South Carolina with accessible, high-quality, coordinated and cost-effective genetic services through a collaborative approach to providing medical care. The two entities have worked together informally on clinical consultations, provider education and research for more than a decade. This affiliation seeks to formalize and expand the depth and breadth of the relationship. According to MUSC, a partnership with the state’s most advanced and innovative genetic center was an easy choice.
“I live in Greenwood, and I’ve said for years that a lot people don’t understand what an absolute gem this center is,” said Charles Schulze, chairman of the MUSC Board of Trustees. “They’ve helped almost 100,000 families across the state make incredibly important decisions, unmasked difficult-to-diagnose conditions, and have been there for these families every step of the way when faced with good news, or not so good news.”
While there are any number of reasons people may want to learn more about how their genetics may affect their or their loved ones health, all patients want the same thing: high-quality care at the lowest cost and access to the latest technologies, diagnostics and research related to their genetic stories. In the interest of better serving these needs, the initial goals of the partnership include:
- Increasing access to clinical genetic services for MUSC patients and all South Carolinians
- Optimizing the patient journey to improve wait times for appointments and consultations
- Sharing critical resources and expertise where possible to lower costs
- Pursuing workforce development, research, clinical trials and treatment collaborations.
Nearly every child in South Carolina who was diagnosed with a genetic birth defect, developmental delay or other hereditary disorder has already been referred to GGC, due to the center’s expertise with rare conditions and commitment to new technologies and diagnostics. GGC, a nonprofit institute centered on research, clinical genetic services, diagnostic laboratory testing and educational programs and resources, is focused on compassionate patient care and innovative scientific advancement.
About Greenwood Genetic Center
The Greenwood Genetic Center (GGC), founded in 1974, is a nonprofit organization advancing the field of medical genetics and caring for families impacted by genetic disease and birth defects. At its home campus in Greenwood, South Carolina, a talented team of physicians and scientists provides clinical genetic services, diagnostic laboratory testing, educational programs and resources, and research in the field of medical genetics. GGC’s faculty and staff are committed to the goal of developing preventive and curative therapies for the individuals and families they serve. GGC extends its reach as a resource to all residents of South Carolina with satellite offices in Charleston, Columbia, Florence and Greenville. For more information about GGC please visit www.ggc.org.